Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00106938 · ClinicalTrials.gov registry record · NA
Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I)
A NA study, sponsored by Abbott Medical Devices.
- Terminated
- Registry status
- NA
- Development phase
- 1,663
- Enrollment target
NCT00106938 is a NA study that was terminated before completion, run by Abbott Medical Devices. The registered enrollment target is 1,663 participants.
The verdict
NCT00106938, a NA study, was terminated before completion, sponsored by Abbott Medical Devices.
- TERMINATED
- Registry status
- NA
- Development phase
- 1,663 participants
- Enrollment target
Study Summary
The study is being conducted to demonstrate the non-inferiority of carotid artery stenting (CAS) using the Emboshield® Embolic Protection System with the Xact® Carotid Stent System to carotid endarterectomy (CEA) for the treatment of asymptomatic extracranial carotid atherosclerotic disease.
Interventions
- DEVICE Carotid artery stenting with filter (interventional)
- PROCEDURE Carotid artery endarterectomy (surgical)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,663 participants |
| Start Date | 2005-04 |
| Est. Completion | 2013-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00106938
The ClinicalTrials.gov registry entry for NCT00106938 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1,663 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Carotid artery stenting with filter (interventional) is the first listed.
NCT00106938 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00106938 about?
NCT00106938 is a clinical study titled "Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I)". The study is being conducted to demonstrate the non-inferiority of carotid artery stenting (CAS) using the Emboshield® Embolic Protection System with the Xact® Carotid Stent System to carotid endarterectomy (CEA) for the treatment of asymptomatic extracranial carotid atherosclerotic disease.
What is the current status of trial NCT00106938?
This trial is currently terminated. It is a NA study. The enrollment target is 1,663 participants. The study started on 2005-04. Estimated completion is 2013-03.
What interventions are being tested in trial NCT00106938?
The interventions under investigation include: Carotid artery stenting with filter (interventional) (DEVICE), Carotid artery endarterectomy (surgical) (PROCEDURE).
Who is sponsoring clinical trial NCT00106938?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.